Cargando…
Analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node
This study was designed to investigate the relationship between prognosis of pancreatic head cancer and status of para‐aortic lymph node (PALN). A total of 233 patients with pancreatic head cancer who underwent surgical resection between February 2008 and October 2015 were enrolled in this study. Un...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083722/ https://www.ncbi.nlm.nih.gov/pubmed/27541833 http://dx.doi.org/10.1002/cam4.853 |
_version_ | 1782463264464044032 |
---|---|
author | Lin, Jian‐yu Zhang, Xing‐mao Kou, Jian‐tiao Fa, Hua Zhang, Xin‐xue Dai, Yang He, Qiang |
author_facet | Lin, Jian‐yu Zhang, Xing‐mao Kou, Jian‐tiao Fa, Hua Zhang, Xin‐xue Dai, Yang He, Qiang |
author_sort | Lin, Jian‐yu |
collection | PubMed |
description | This study was designed to investigate the relationship between prognosis of pancreatic head cancer and status of para‐aortic lymph node (PALN). A total of 233 patients with pancreatic head cancer who underwent surgical resection between February 2008 and October 2015 were enrolled in this study. Univariate and multivariate analyses were used to reveal the prognostic factors. Prognostic factors for patients with and without metastasis of PALN were analyzed, respectively. The 5‐year overall survival (OS) rate was 19.0% for all patients, and the positive rate of PALN metastasis was 18.9% (44/233). The 1‐, 2‐, 3‐, and 5‐year OS rates in patients without metastasis of PALN were 79.4%, 54.8%, 36.4%, and 22.9%, respectively, whereas the 1‐, 2‐, and 3‐year survival rates were 54.0%, 14.8%, and 0%, respectively, in patients with metastasis of PALN. Preoperative CA19‐9 level, tumor size, T status, N status, and adjuvant therapy were independent prognostic factors for all patients confirmed by multivariate analysis. For patients without PALN metastasis, back pain, tumor size, T status, N status, portal or superior mesenteric vein invasion, and adjuvant therapy were independent prognostic factors, while the only one influence factor for 2‐year OS was adjuvant therapy for patients with metastasis of PALN. Metastasis of PALN was associated with poor prognosis for patients with pancreatic head cancer. Patients with and without metastasis of PALN had different prognostic factors, and adjuvant therapy was the only prognostic factor for patients with metastasis of PALN. |
format | Online Article Text |
id | pubmed-5083722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50837222016-10-31 Analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node Lin, Jian‐yu Zhang, Xing‐mao Kou, Jian‐tiao Fa, Hua Zhang, Xin‐xue Dai, Yang He, Qiang Cancer Med Clinical Cancer Research This study was designed to investigate the relationship between prognosis of pancreatic head cancer and status of para‐aortic lymph node (PALN). A total of 233 patients with pancreatic head cancer who underwent surgical resection between February 2008 and October 2015 were enrolled in this study. Univariate and multivariate analyses were used to reveal the prognostic factors. Prognostic factors for patients with and without metastasis of PALN were analyzed, respectively. The 5‐year overall survival (OS) rate was 19.0% for all patients, and the positive rate of PALN metastasis was 18.9% (44/233). The 1‐, 2‐, 3‐, and 5‐year OS rates in patients without metastasis of PALN were 79.4%, 54.8%, 36.4%, and 22.9%, respectively, whereas the 1‐, 2‐, and 3‐year survival rates were 54.0%, 14.8%, and 0%, respectively, in patients with metastasis of PALN. Preoperative CA19‐9 level, tumor size, T status, N status, and adjuvant therapy were independent prognostic factors for all patients confirmed by multivariate analysis. For patients without PALN metastasis, back pain, tumor size, T status, N status, portal or superior mesenteric vein invasion, and adjuvant therapy were independent prognostic factors, while the only one influence factor for 2‐year OS was adjuvant therapy for patients with metastasis of PALN. Metastasis of PALN was associated with poor prognosis for patients with pancreatic head cancer. Patients with and without metastasis of PALN had different prognostic factors, and adjuvant therapy was the only prognostic factor for patients with metastasis of PALN. John Wiley and Sons Inc. 2016-08-19 /pmc/articles/PMC5083722/ /pubmed/27541833 http://dx.doi.org/10.1002/cam4.853 Text en © 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Lin, Jian‐yu Zhang, Xing‐mao Kou, Jian‐tiao Fa, Hua Zhang, Xin‐xue Dai, Yang He, Qiang Analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node |
title | Analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node |
title_full | Analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node |
title_fullStr | Analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node |
title_full_unstemmed | Analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node |
title_short | Analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node |
title_sort | analysis of prognostic factors for pancreatic head cancer according to para‐aortic lymph node |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083722/ https://www.ncbi.nlm.nih.gov/pubmed/27541833 http://dx.doi.org/10.1002/cam4.853 |
work_keys_str_mv | AT linjianyu analysisofprognosticfactorsforpancreaticheadcanceraccordingtoparaaorticlymphnode AT zhangxingmao analysisofprognosticfactorsforpancreaticheadcanceraccordingtoparaaorticlymphnode AT koujiantiao analysisofprognosticfactorsforpancreaticheadcanceraccordingtoparaaorticlymphnode AT fahua analysisofprognosticfactorsforpancreaticheadcanceraccordingtoparaaorticlymphnode AT zhangxinxue analysisofprognosticfactorsforpancreaticheadcanceraccordingtoparaaorticlymphnode AT daiyang analysisofprognosticfactorsforpancreaticheadcanceraccordingtoparaaorticlymphnode AT heqiang analysisofprognosticfactorsforpancreaticheadcanceraccordingtoparaaorticlymphnode |